Former Medtronic CEO Bill George joins CNBC’s “Squawk Alley” via phone to talk about the merger between Bristol-Myers and Celgene.
Celgene deal is a ‘bold’ move, says former Medtronic CEO from CNBC.
Jan 3, 2019
Former Medtronic CEO Bill George joins CNBC’s “Squawk Alley” via phone to talk about the merger between Bristol-Myers and Celgene.
Celgene deal is a ‘bold’ move, says former Medtronic CEO from CNBC.